help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorudi, S.
Right arrow Articles by Hart, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorudi, S.
Right arrow Articles by Hart, I. R.

American Journal of Pathology, Vol 142, 981-986, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study

S Dorudi, JP Sheffield, R Poulsom, JM Northover and IR Hart
Imperial Cancer Research Fund Colorectal Cancer Unit, St. Mark's Hospital, London, United Kingdom.

Expression of the epithelial-specific adhesion molecule E-cadherin has been assessed in paraffin-embedded tissue from a series of 72 colorectal carcinomas. Using immunocytochemistry and in situ hybridization it was found that E-cadherin expression was related inversely to tumor differentiation. Out of 44 well- and moderately differentiated tumors, 36 expressed good positivity, whereas 24 of 28 poorly differentiated tumors were E-cadherin-negative. Classification by Dukes stage revealed a highly significant difference (P << 0.001) between A and B (32 positive, four negative) and C1 and C2 (seven positive, 29 negative) stages in terms of immunoreactivity. Of the 32 lymph node metastases studied, 20 were negative for E-cadherin expression, as were seven of eight liver metastases. These results indicate that the down-regulation of E-cadherin levels in vivo is associated with the dedifferentiation, progression, and metastasis of colorectal cancer.


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Mauro, S. Catalano, G. Bossi, M. Pellegrino, I. Barone, S. Morales, C. Giordano, V. Bartella, I. Casaburi, and S. Ando
Evidences that Leptin Up-regulates E-Cadherin Expression in Breast Cancer: Effects on Tumor Growth and Progression
Cancer Res., April 1, 2007; 67(7): 3412 - 3421.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. S. Munday, M. M. Brennan, and M. Kiupel
Altered Expression of {beta}-catenin, E-cadherin, Cycloxygenase-2, and p53 Protein by Ovine Intestinal Adenocarcinoma Cells.
Vet. Pathol., September 1, 2006; 43(5): 613 - 621.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. J. Fidler
Blockade of the TGF-{beta} Superfamily by Smad7: Breaking a Link in the Metastatic Chain
J Natl Cancer Inst, December 7, 2005; 97(23): 1714 - 1715.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K S Nair, R Naidoo, and R Chetty
Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value
J. Clin. Pathol., April 1, 2005; 58(4): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al.
Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Okazaki, N. Takahashi, S.-i. Kojima, Y. Masuho, and H. Koga
Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation
Carcinogenesis, July 1, 2002; 23(7): 1139 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
R J Campbell and M Pignatelli
Molecular histology in the study of solid tumours
Mol. Pathol., April 1, 2002; 55(2): 80 - 82.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A O O Chan, S K Lam, K M Chu, C M Lam, E Kwok, S Y Leung, S T Yuen, S Y K Law, W M Hui, K C Lai, et al.
Soluble E-cadherin is a valid prognostic marker in gastric carcinoma
Gut, June 1, 2001; 48(6): 808 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M von Schlippe, J. Marshall, P Perry, M Stone, A. Zhu, and I. Hart
Functional interaction between E-cadherin and alphav-containing integrins in carcinoma cells
J. Cell Sci., January 2, 2000; 113(3): 425 - 437.
[Abstract] [PDF]


Home page
J. Cell Biol.Home page
M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of their E-Cadherin Expression
J. Cell Biol., November 1, 1999; 147(3): 631 - 644.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. Pötter, C. Bergwitz, and G. Brabant
The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues
Endocr. Rev., April 1, 1999; 20(2): 207 - 239.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
H. Kuniyasu, L. M. Ellis, D. B. Evans, J. L. Abbruzzese, C. J. Fenoglio, C. D. Bucana, K. R. Cleary, E. Tahara, and I. J. Fidler
Relative Expression of E-Cadherin and Type IV Collagenase Genes Predicts Disease Outcome in Patients with Resectable Pancreatic Carcinoma
Clin. Cancer Res., January 1, 1999; 5(1): 25 - 33.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
J. C. Machado, F. Carneiro, S. Beck, S. Rossi, J. Lopes, A. Taveira-Gomes, and M. Cardoso-Oliveira
E-Cadherin Expression Is Correlated with the Isolated Cell/Diffuse Histotype and with Features of Biological Aggressiveness of Gastric Carcinoma
International Journal of Surgical Pathology, July 1, 1998; 6(3): 135 - 144.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. SULZER, M. P. G. LEERS, J. A. van NOORD, E. C. M. BOLLEN, and P. H. M. H. THEUNISSEN
Reduced E-Cadherin Expression Is Associated with Increased Lymph Node Metastasis and Unfavorable Prognosis in Non-small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1319 - 1323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. B. Stewart and W. J. Nelson
Identification of Four Distinct Pools of Catenins in Mammalian Cells and Transformation-dependent Changes in Catenin Distributions among These Pools
J. Biol. Chem., November 21, 1997; 272(47): 29652 - 29662.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A Tang, M. Eller, M Hara, M Yaar, S Hirohashi, and B. Gilchrest
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro
J. Cell Sci., January 4, 1994; 107(4): 983 - 992.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Kitada, E. Miyoshi, K. Noda, S. Higashiyama, H. Ihara, N. Matsuura, N. Hayashi, S. Kawata, Y. Matsuzawa, and N. Taniguchi
The Addition of Bisecting N-Acetylglucosamine Residues to E-cadherin Down-regulates the Tyrosine Phosphorylation of beta -Catenin
J. Biol. Chem., January 5, 2001; 276(1): 475 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Orlandini and S. Oliviero
In Fibroblasts Vegf-D Expression Is Induced by Cell-Cell Contact Mediated by Cadherin-11
J. Biol. Chem., February 23, 2001; 276(9): 6576 - 6581.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.